# Adaptimmune Ltd — Form D

Adaptimmune Ltd of ABINGDON, OXFORDSHIRE, X0, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-02. The offering totals $103.8M, of which $103.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-10-02
- Form: D
- Accession: 0001621227-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $103.8M
- Amount sold: $103.8M
- Minimum investment: $1
- Investors: 22
- Date of first sale: 2014-09-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-225667

## Issuer

- Name: Adaptimmune Ltd
- CIK: 0001621227
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Address: 91 PARK DRIVE, ABINGDON, OXFORDSHIRE, X0, OX14 4RY
- Phone: 44 1235 430000

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Ali Behbahani | Director | Littleton, CO |
| Dr. Jonathan Knowles | Director | Abingdon, Oxfordshire, X0 |
| Ian Laing | Director | Abingdon, Oxfordshire, X0 |
| David Mott | Director | Chevy Chase, MD |
| James Noble | Director | Abingdon, Oxfordshire, X0 |
| Elliott Sigal | Director | WALTHAM, MA |
| Peter Thompson | Director | Chanhassen, MN |
| James Noble | Executive Officer | Abingdon, Oxfordshire, X0 |

## More

- [CIK 1621227 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1621227&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001621227-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.